PHARMACOKINETIC PROPERTIES AND BIOAVAILABILITY OF METHIMAZOLE

被引：34
作者：
JANSSON, R
LINDSTROM, B
DAHLBERG, PA
机构：
[1] UNIV HOSP UPPSALA, DEPT INTERNAL MED, S-75185 UPPSALA, SWEDEN
[2] NATL BOARD HLTH & WELFARE, DEPT DRUGS, UPPSALA, SWEDEN
来源：
CLINICAL PHARMACOKINETICS | 1985年 / 10卷 / 05期
关键词：
D O I：
10.2165/00003088-198510050-00006
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：443 / 450
页数：8
相关论文
共 24 条
[1]   METABOLISM OF 35S-LABELLED ANTITHYROID DRUGS IN MAN [J].
ALEXANDER, WD ;
EVANS, V ;
MACAULAY, A ;
GALLAGHER, TF ;
LONDONO, J .
BMJ-BRITISH MEDICAL JOURNAL, 1969, 2 (5652) :290-+
[2]   TREATMENT OF HYPERTHYROIDISM WITH PROPYLTHIOURACIL [J].
ASTWOOD, EB ;
VANDERLAAN, WP .
ANNALS OF INTERNAL MEDICINE, 1946, 25 (05) :813-821
[3]  
BALTZER J, 1975, DEUT MED WOCHENSCHR, V100, P548
[4]   METHIMAZOLE PHARMACOLOGY IN MAN - STUDIES USING A NEWLY DEVELOPED RADIOIMMUNOASSAY FOR METHIMAZOLE [J].
COOPER, DS ;
BODE, HH ;
NATH, B ;
SAXE, V ;
MALOOF, F ;
RIDGWAY, EC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 58 (03) :473-479
[5]  
CROOKS J, 1973, BRIT J PHARMACOL, V49, pP156
[6]   STUDIES OF THYROID-HORMONE AND METHIMAZOLE LEVELS IN PATIENTS WITH GRAVES-DISEASE ON A STANDARDIZED ANTI-THYROID DRUG REGIMEN [J].
DAHLBERG, PA ;
KARLSSON, FA ;
LINDSTROM, B ;
WIDE, L .
CLINICAL ENDOCRINOLOGY, 1981, 14 (06) :555-562
[7]   DETERMINATION OF METHIMAZOLE IN PLASMA USING GAS CHROMATOGRAPHY-MASS SPECTROMETRY AFTER EXTRACTIVE ALKYLATION [J].
FLOBERG, S ;
LANBECK, K ;
LINDSTROM, B .
JOURNAL OF CHROMATOGRAPHY, 1980, 182 (01) :63-70
[8]   IGPHARM - INTERACTIVE GRAPHIC PACKAGE FOR PHARMACOKINETIC ANALYSIS [J].
GOMENI, C ;
GOMENI, R .
COMPUTERS AND BIOMEDICAL RESEARCH, 1978, 11 (04) :345-361
[9]   INFLUENCE OF HYPERTHYROIDISM ON THE KINETICS OF METHIMAZOLE, PROPRANOLOL, METOPROLOL AND ATENOLOL [J].
HALLENGREN, B ;
NILSSON, OR ;
KARLBERG, BE ;
MELANDER, A ;
TEGLER, L ;
WAHLINBOLL, E .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 21 (05) :379-384
[10]  
JANSSON R, 1983, INT J CLIN PHARM TH, V21, P505
123